HELIOS CARDIO INC.
With 20 years of expertise in regenerative tissue engineering, Helios Cardio applies the most advanced regenerative tissue scaffold technology to cardiac tissue repair. Combining market-leading mechanical properties, exceptional tissue regeneration characteristics, and proven safety through clinical use in more than 500,000 patients, CardiaMend™ represents a new dawn in cardiac tissue engineering.CardiaMend™ provides not only mechanical support to cardiac structures, but also the optimal environment for patients' own tissue to grow into and regenerate.This truly regenerative material opens up new avenues in cardiac care. Helios Cardio is also participating in cutting edge research by combining the mechanotransductive properties of CardiaMend™ with stem cells to provide transformative regenerative strategies for patients suffering from heart failure.
Country/Area ：United States
Company Email ：support@helioscardio.com
Industry ：HospitalityFitness & Dance FacilitiesRecreationElectronicsConstruction & Real EstateChemical EngineeringLights & Lighting
Company address ：11 Dellbrook Rd Weston 02493 Us
Company website ：*****
Company phone ：(617) 818-4008
Established ：2016
Company Revenue ：$3,013,000
Number of employees ：3
SIC Code ：79799
NAICS Code ：71713
Main Products ：Fetal Engineered Biologic Matrix (f-EBM)CardiaMend™ Pericardial and Epicardial Reconstruction Matrix
Company News
Helios Cardio Awarded a spot on FSS, DAPA, and ECAT Contracts Through Lovell Government Services
Aug 30, 2022
Helios Cardio’s CardiaMend™ is now available on Lovell’s Contract Vehicles. PENSACOLA, FL, UNITED STATES, August 30, 2022 /EINPresswire.com/ -- Helios Cardio Inc. announced today that its flagship implantable biologic device, CardiaMend™ Pericardial and …
Aug 30, 2022
Web Summary
Q1: What is the address of Helios Cardio Inc.?
A1: The company has two addresses - one in Weston, MA (11 Dellbrook Road) and another in Natick, MA (22 Strathmore Road).
Q2: What products does Helios Cardio Inc. offer?
A2: According to the provided content, Helios Cardio Inc. offers CardiaMend, a biomaterial for cardiac repair and regeneration, as well as other novel cell and pharmaco- therapies in combination with CardiaMend.
Q3: In which industry is Helios Cardio Inc. operating?
A3: Helios Cardio Inc. operates in the field of regenerative medicine and cardiothoracic surgery, specifically focusing on cardiac repair and regeneration technologies.
Q4: What services does Helios Cardio Inc. provide to its customers?
A4: The company provides clinical research opportunities, product availability information, and collaboration with innovative cardiac surgeons to bring new innovations into the clinic.
Q5: Who are some of the key members of Helios Cardio's management team?
A5: The management team includes Yiannis Monovoukas (Founder and CEO), Peter Jackson (Chief Commercial Officer), Clayton Kaiser (Chief Medical Officer), and Kevin Cornwell (Chief Scientific Officer).
Q6: What is the mission of Helios Cardio Inc.?
A6: The company's mission is to provide cardiac surgeons with transformative technologies to tackle some of the toughest problems in cardiac health.
Q7: Who are some of the advisors guiding Helios Cardio Inc.?
A7: The company is guided by a team of world-renowned experts in cardiothoracic surgery, regenerative medicine, and biomedical engineering, including Pedro J. del Nido, William E. Ladd, Gus Vlahakes, Ellen Roche, and others.
Q8: How can one contact Helios Cardio Inc. for further information?
A8: The company can be contacted through their website, phone number (+1 339-707-7788), or email (not explicitly provided in the text).
A1: The company has two addresses - one in Weston, MA (11 Dellbrook Road) and another in Natick, MA (22 Strathmore Road).
Q2: What products does Helios Cardio Inc. offer?
A2: According to the provided content, Helios Cardio Inc. offers CardiaMend, a biomaterial for cardiac repair and regeneration, as well as other novel cell and pharmaco- therapies in combination with CardiaMend.
Q3: In which industry is Helios Cardio Inc. operating?
A3: Helios Cardio Inc. operates in the field of regenerative medicine and cardiothoracic surgery, specifically focusing on cardiac repair and regeneration technologies.
Q4: What services does Helios Cardio Inc. provide to its customers?
A4: The company provides clinical research opportunities, product availability information, and collaboration with innovative cardiac surgeons to bring new innovations into the clinic.
Q5: Who are some of the key members of Helios Cardio's management team?
A5: The management team includes Yiannis Monovoukas (Founder and CEO), Peter Jackson (Chief Commercial Officer), Clayton Kaiser (Chief Medical Officer), and Kevin Cornwell (Chief Scientific Officer).
Q6: What is the mission of Helios Cardio Inc.?
A6: The company's mission is to provide cardiac surgeons with transformative technologies to tackle some of the toughest problems in cardiac health.
Q7: Who are some of the advisors guiding Helios Cardio Inc.?
A7: The company is guided by a team of world-renowned experts in cardiothoracic surgery, regenerative medicine, and biomedical engineering, including Pedro J. del Nido, William E. Ladd, Gus Vlahakes, Ellen Roche, and others.
Q8: How can one contact Helios Cardio Inc. for further information?
A8: The company can be contacted through their website, phone number (+1 339-707-7788), or email (not explicitly provided in the text).
Customs Data
As a purchaser
As a Supplier
Get the Whole details
Contact
Total found ??? Contacts
All
Boss
Management
Procurement
Other
Get the Whole details
